BIOLASE, INC Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Biolase, Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2011 to Q3 2024.
  • Biolase, Inc Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $51K, a 81.5% decline year-over-year.
  • Biolase, Inc Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $299K, a 82% decline year-over-year.
  • Biolase, Inc annual Share-based Payment Arrangement, Expense for 2023 was $1.23M, a 46.5% decline from 2022.
  • Biolase, Inc annual Share-based Payment Arrangement, Expense for 2022 was $2.3M, a 38.6% increase from 2021.
  • Biolase, Inc annual Share-based Payment Arrangement, Expense for 2021 was $1.66M, a 50.7% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $299K $51K -$225K -81.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $524K -$46K -$130K -155% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $654K $113K -$578K -83.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $1.23M $181K -$432K -70.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 $1.66M $276K -$315K -53.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $1.98M $84K -$806K -90.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $2.79M $691K +$482K +231% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $2.3M $613K +$437K +248% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 $1.87M $591K +$399K +208% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $1.47M $890K +$524K +143% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $943K $209K -$719K -77.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $1.66M $176K -$827K -82.5% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-21
Q3 2021 $2.49M $192K -$655K -77.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $3.14M $366K -$435K -54.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $3.58M $928K +$209K +29.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $3.37M $1M +$235K +30.6% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-28
Q3 2020 $3.14M $847K +$77K +10% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $3.06M $801K +$354K +79.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $2.7M $719K -$38K -5.02% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $2.74M $768K -$138K -15.2% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-17
Q3 2019 $2.88M $770K +$166K +27.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 $2.71M $447K -$110K -19.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $2.82M $757K +$56K +7.99% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $2.77M $906K +$303K +50.2% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-31
Q3 2018 $2.47M $604K +$140K +30.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $2.33M $557K -$204K -26.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $2.53M $701K +$322K +85% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $2.21M $603K +$6K +1.01% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-30
Q3 2017 $2.2M $464K -$224K -32.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $2.43M $761K -$185K -19.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 $2.61M $379K -$455K -54.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 $3.07M $597K -$497K -45.4% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-08
Q3 2016 $3.56M $688K +$67K +10.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-01
Q2 2016 $3.5M $946K +$11K +1.18% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $3.48M $834K +$134K +19.1% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $3.35M $1.09M Oct 1, 2015 Dec 31, 2015 10-K 2018-03-14
Q3 2015 $621K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 $935K +$659K +239% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-01
Q1 2015 $700K +$390K +126% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q2 2014 $1.45M $276K -$104K -27.4% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $1.55M $310K -$58K -15.8% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-01
Q4 2013 $1.61M $370K +$50K +15.6% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-11
Q3 2013 $1.56M $491K +$134K +37.5% Jul 1, 2013 Sep 30, 2013 10-Q 2013-11-12
Q2 2013 $1.43M $380K +$40K +11.8% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 $1.39M $368K -$215K -36.9% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $1.6M $320K Oct 1, 2012 Dec 31, 2012 10-K 2015-03-06
Q3 2012 $357K +$33K +10.2% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $340K -$116K -25.4% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 $583K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q3 2011 $324K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 $456K Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-09-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.